By Josh White
Date: Thursday 14 Aug 2025
(Sharecast News) - SkinBioTherapeutics said in an update on Thursday that revenue for the year ended 30 June were expected to rise almost fourfold to between £4.5m and £4.8m, driven by a full-year contribution from Dermatonics, eight months from Bio-Tech Solutions (BTS), and continued organic growth in AxisBiotix sales.
By Josh White
Date: Monday 16 Jun 2025
(Sharecast News) - SkinBioTherapeutics announced on Monday that it has signed an exclusive UK commercial agreement with Superdrug for its 'AxisBiotix' range of food supplements targeting inflammatory skin conditions, while also raising £4.1m through a placing and subscription to support the rollout and related operational needs.
By Benjamin Chiou
Date: Friday 11 Oct 2024
(Sharecast News) - AIM-listed life sciences company SkinBioTherapeutics has announced the acquisition of Yorkshire-based health, hygiene and personal care products group Bio-Tech Solutions for £1.25m.
Currency | UK Pounds |
Share Price | 14.13p |
Change Today | -0.13p |
% Change | -0.88 % |
52 Week High | 26.10p |
52 Week Low | 13.25p |
Volume | 576,673 |
Shares Issued | 258.78m |
Market Cap | £36.55m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:20 | 803 @ 14.00p |
16:18 | 1,700 @ 14.14p |
16:14 | 10,000 @ 14.14p |
14:00 | 38,143 @ 14.10p |
14:00 | 38,143 @ 14.10p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research